e-edition eEdition Subscribe Log in
Monday, October 07, 2024
44.0°F
Charles Albright, executive vice president and chief scientific officer at Editas Medicine, a genome-editing company, in Cambridge, Mass., walks through the company's office on Jan. 8, 2020. “We literally have the potential to take people who are essentially blind and make them see,” said Albright, whose company is developing a gene editing treatment for blindness with Dublin-based Allergan. “We think it could open up a whole new set of medicines to go in and change your DNA." (AP Photo/Rodrique Ngowi)

Charles Albright, executive vice president and chief scientific officer at Editas Medicine, a genome-editing company, in Cambridge, Mass., walks through the company's office on Jan. 8, 2020. “We literally have the potential to take people who are essentially blind and make them see,” said Albright, whose company is developing a gene editing treatment for blindness with Dublin-based Allergan. “We think it could open up a whole new set of medicines to go in and …

March 4, 2020

Stories this photo appears in:

Doctors try 1st CRISPR editing in the body for blindness
March 4, 2020 11:48 a.m.

Doctors try 1st CRISPR editing in the body for blindness

Scientists say they have used the gene editing tool CRISPR inside someone's body for the first time, a new frontier for efforts to operate on DNA, the chemical code of life, to treat diseases.